Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 28, 2006; 12(12): 1924-1932
Published online Mar 28, 2006. doi: 10.3748/wjg.v12.i12.1924
Published online Mar 28, 2006. doi: 10.3748/wjg.v12.i12.1924
Variable | P value | Exp (B) | 95% CI for Exp (B) |
Age | NS | 1.0085 | 0.9541-1.0660 |
Stage | NS | 2.0919 | 0.2317-18.8828 |
Grade | NS | 0.2272 | 0.0475-1.0855 |
PECAM-1 tumor expression | P < 0.01 | 19.9490 | 2.7865-142.8178 |
HLA-DR tumor expression | P < 0.05 | 0.1373 | 0.0258-0.7299 |
- Citation: Darom A, Gomatos IP, Leandros E, Chatzigianni E, Panousopoulos D, Konstadoulakis MM, Androulakis G. Molecular markers (PECAM-1, ICAM-3, HLA-DR) determine prognosis in primary non-Hodgkin’s gastric lymphoma patients. World J Gastroenterol 2006; 12(12): 1924-1932
- URL: https://www.wjgnet.com/1007-9327/full/v12/i12/1924.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i12.1924